Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma.
Eur J Cancer
; 109: 61-69, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30690294
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Brain Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Proto-Oncogene Proteins B-raf
/
Melanoma
/
Mutation
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Cancer
Year:
2019
Type:
Article